Innovation
²ÝÝ®ÊÓƵ-affiliated physicians benefit from new technology and care solution investments to detect disease earlier, provide patient-centered care and increase survival rates.
²ÝÝ®ÊÓƵ pushes for what health care could be. We are driving innovation by improving care delivery, developing cutting-edge technology and advancing new models of care.
Proven Results
Through a dedication to quality care, innovation and a community-focused culture, Davita-affiliated physicians have continuously helped improve clinical results and health care costs for kidney patients.
#3
²ÝÝ®ÊÓƵ ranked #3 in innovation among health care medical facilities on the 2022 FORTUNE® World’s Most Admired Companies® list.2
29k
²ÝÝ®ÊÓƵ has the largest home dialysis population in the U.S.3
300k
As a leader in kidney education, ²ÝÝ®ÊÓƵ’s no-cost Kidney Smart® program has educated more than 300,000 people since 2012.4
28%
Reduction in overall ESKD hospitalization rate.5
36%
Increase in patients treating at home.6
23%
From 2006 to 2016, dialysis patients’ survival improved by 22.6 %.1
Supportive Technology
Leading-edge technologies support better patient engagement, clinical insights, efficiencies and health outcomes.
Renal-specific EHR
Helps improve workflow, enables better care coordination and increases practice efficiency.
AI and risk analytics
Aid in population health management and developing individualized care plans.
Remote monitoring and telehealth
Capabilities aim to increase patients' comfort with home dialysis and connect them with clinicians in real time.
Solution Investments
²ÝÝ®ÊÓƵ has made the following investments to fuel innovation for our patients:
Education for Every Stage
Kidney Smart® classes help patients better manage their CKD and prepare for dialysis.
²ÝÝ®ÊÓƵ Start Smart™ educates and supports new dialysis patients with treatment options and lifestyle changes.
Transition of Care educates patients for a smooth transition to dialysis.
Transplant Smart® aims to educate 100% of our patients on the kidney transplant process.
1 USRDS Annual Data Report, 2018, Volume II, ch. 5 | 2 From Fortune. ©2022 Fortune Media IP Limited. All rights reserved. Used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of, ²ÝÝ®ÊÓƵ Inc. | 3 Nephrology New & Issues. July 2017 | 4 Internal ²ÝÝ®ÊÓƵ data, 2012-2018 | 5 Data based on performance in an ESKD shared savings program with a private payor (Commercial and Medicare Advantage members) | 6 National commercial ESKD program, over 4 years of program